Year: 2025

Company announcement no. 33 / 2025Schindellegi, Switzerland – 9 June 2025 Trifork Group: Weekly report on share buyback On 28 February 2025, Trifork initiated a share buyback program in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buyback program runs from 4 March 2025 up to and including no later than 30 June 2025. For details, please see company announcement no. 7 of 28 February 2025. Under the share buyback program, Trifork will purchase shares for up to a total of DKK 14.92 million (approximately EUR 2 million). Prior to the launch of the share buyback, Trifork held 256,329 treasury shares, corresponding to 1.3% of the share capital. Under the program, the following transactions have been...

The Supervisory Board of AS LHV Group has elected Mihkel Torim as Chairman of the Management Board and CEO of LHV Group. He currently serves as Head of Investment Banking at LHV Bank. Torim will assume the role on 22 July 2025, succeeding Madis Toomsalu, who announced his intention to step down earlier this year after serving as CEO since 2016. Mihkel Torim is a seasoned leader in capital markets and investment banking, with over 20 years of experience across financial institutions in the Baltics and Northern Europe. He joined LHV in early 2023 to lead the bank’s investment banking operations. Prior to that, he held senior positions at Swedbank, including as Head of Baltic Investment Banking and Manager of the Finnish investment banking unit. As Chairman of the LHV Group’s Management Board, Torim has also been elected to the Supervisory...

Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Paris, June 9, 2025. Sanofi is shipping Beyfortus (nirsevimab) starting in early Q3 to ensure broad availability well ahead of the 2025-2026 respiratory syncytial virus (RSV) season, which typically starts in November and runs through March. Immunizations begin in early fall and these advance shipments provide confidence for healthcare providers to support their efforts. Demand has continued to increase since the launch of Beyfortus, the only option that can offer RSV protection designed for all infants with proven high, sustained efficacy through a typical RSV season and an unparalleled body of real-world evidence. Sanofi, in collaboration with its partner AstraZeneca, has tripled production capacity and doubled the number...

Amsterdam, 9 June 2025 — AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) is pleased to announce that Mr. Thomas Swoboda has been appointed the new global Head of Investor Relations, effective immediately. He is the successor to Ms. Michele Fischer, who has held that position for the last six years and has transitioned to Head of Human Resources on a global level as Executive Vice President. Thomas brings over 18 years of international capital market experience with him. He joins AMG from Société Generale/Bernstein, where he was Director of Equity Research since 2015. Before that, he was a Senior Equity Analyst at MainFirst Bank/Stifel. Thomas holds a degree in Business Administration from Mannheim University, where he was a recipient of the Research Award of the Prechel-Stiftung. He is multilingual,...

HOUSTON, Texas (09 June 2025) – TGS, a global leader in energy data and intelligence, has announced a strategic partnership with Oseberg, a premier provider of lease and regulatory data for the energy sector. This collaboration brings Oseberg lease data attributes into TGS’ Well Data Analytics (WDA) platform for enhanced analysis. In the first phase of the integration, WDA users can now seamlessly access lease ownership data for Texas, New Mexico, and Oklahoma, as well as other subsurface well data. This combined offering enables E&P companies to plan wells more efficiently, reduce legal and operational risks, and optimize development strategies by aligning drilling programs with land ownership and leasehold constraints. Key use cases include merger and acquisition analysis, project site planning, investment evaluation, and resource...

The Supervisory Board of AS LHV Pank, subsidiary of AS LHV Group, has elected Mihkel Kasepuu as a Member of the Management Board, with responsibility for technology and product development. Whether the new board member meets the eligibility requirements will also be approved bv the ECB. Kasepuu will assume his new position on 22, July for a five-year term. Mihkel Kasepuu has served as LHV Pank’s Chief Technology Officer and Chief Technology and Product Officer since 2024. Previously, he worked at Nortal from 2015 to 2023. At LHV, he has played a key role in building scalable, secure systems and driving product innovation. His expertise will be central to advancing the bank’s digital capabilities. Kasepuu holds a master’s degree in IT from Taltech. He is a shareholder and a management board member in several small IT consultancy and software...

MACAU, June 09, 2025 (GLOBE NEWSWIRE) — Melco Resorts & Entertainment Limited (Nasdaq: MLCO) (“Melco” or the “Company”), a developer, owner and operator of integrated resort facilities in Asia and Europe, announced that, after considering the Company’s overall development strategy and in accordance with Macau law, Grand Dragon Casino and three Mocha Clubs, namely Mocha Hotel Royal, Mocha Kuong Fat and Mocha Grand Dragon Hotel, will cease operations before the end of 2025. The employees working at these venues will be assigned to work at other properties of the Company in Macau, which will secure continued employment for these employees within their current job duties. Gaming tables and electronic gaming machines operating at the above-mentioned affected venues will also be re-allocated to, and continue operations at,...

The collaboration with OSL, a leading regulated platform in Asia, marks MoneyHero’s strategic expansion into the digital asset landscape, empowering users to make smarter and more informed financial decisions HONG KONG, June 09, 2025 (GLOBE NEWSWIRE) — MoneyHero Limited (NASDAQ: MNY) (“MoneyHero” or the “Company”), a leading personal finance aggregation and comparison platform, as well as a digital insurance brokerage provider in Greater Southeast Asia, today announced a strategic collaboration with OSL Group Limited (HKEX: 863) (“OSL”), Asia’s leading regulated digital asset platform, to expand its digital asset wealth product offerings. This collaboration marks a key step as MoneyHero expands its wealth products offerings in Hong Kong to include digital asset-related services provided by Securities and Futures Commission...

Designed in partnership with Xbox, these incredible new handhelds offer a new software suite, a redesigned chassis, and more KEY POINTSAll-day comfort: Redesigned chassis is purpose-built to fit the hands like a real gamepad Seamless software experience: New Xbox® software offers the best of Xbox and Windows PC gaming in one handheld Efficiency and performance: Two new processors offer incredible AAA and indie gaming experiencesLOS ANGELES, June 08, 2025 (GLOBE NEWSWIRE) — ASUS Republic of Gamers (ROG) is proud to announce an all-new series of Ally handhelds built from the ground up with improved ergonomics and a seamless player-first user experience. Developed in partnership with the incredible team at Xbox, the new ROG Xbox Ally and ROG Xbox Ally X offer best-in-class ergonomics and a full-screen Xbox experience that marries...

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved 75% or greater improvement in overall disease severity, the primary endpoint, in more than three-quarters of treated patients Patients experienced substantial reductions in hyperpigmentation, dry skin and itch from baseline Results support commitment to enhance clinical understanding of chronic diseases in communities of color TARRYTOWN, N.Y. and PARIS, June 07, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today presented results from the DISCOVER Phase 4, single-arm, open-label trial assessing Dupixent® (dupilumab) in adults and adolescents with moderate-to-severe atopic dermatitis with skin of color. These are the first clinical trial results for Dupixent in a large population of patients...